HIV update 2005: Origins, issues, prospects, and complications.

Wendy Armstrong, MD
Department of Infectious Disease, The Cleveland Clinic Foundation

Leonard Calabrese, DO
Department of Rheumatic and Immunologic Disease, The Cleveland Clinic Foundation

Alan J. Taege, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Alan J. Taege, MD, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Taege has indicated that he serves as a consultant for the Glaxo, BMS, Pfizer, and Merck corporations, is on the speakers’ bureaus of the Glaxo, BMS, and Roche corporations, and is a major stock shareholder in the Amgen corporation.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Wendy Armstrong, MD
Department of Infectious Disease, The Cleveland Clinic Foundation

Leonard Calabrese, DO
Department of Rheumatic and Immunologic Disease, The Cleveland Clinic Foundation

Alan J. Taege, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Alan J. Taege, MD, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Taege has indicated that he serves as a consultant for the Glaxo, BMS, Pfizer, and Merck corporations, is on the speakers’ bureaus of the Glaxo, BMS, and Roche corporations, and is a major stock shareholder in the Amgen corporation.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Wendy Armstrong, MD
Department of Infectious Disease, The Cleveland Clinic Foundation

Leonard Calabrese, DO
Department of Rheumatic and Immunologic Disease, The Cleveland Clinic Foundation

Alan J. Taege, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Alan J. Taege, MD, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Taege has indicated that he serves as a consultant for the Glaxo, BMS, Pfizer, and Merck corporations, is on the speakers’ bureaus of the Glaxo, BMS, and Roche corporations, and is a major stock shareholder in the Amgen corporation.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.